Recent Updates
Recently added Catalysts

Dermacid Silver

Phase 3

Undisclosed | Small molecule | Other |Sanofi|Trials Updated: Dec 2, 2010

Dermacid Silver target and mechanism

ModalitySmall molecule

Also known as Dermacid Silver (Lactic acid)

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedCONTROLLED
Total Trials1
Total Enrollment70

FDA Designations

No designations recorded

Dermacid Silver clinical trials

Dermacid Silver · 1 trial · 1 indication

Phase 3 1
NCT01126606Comparative Safety and Efficacy Evaluation Between Dermacyd Silver and Glycerine Vegetal Soap Granado TraditionalHygiene
COMPLETED70 Analytics
PHASE3COMPLETED
Comparative Safety and Efficacy Evaluation Between Dermacyd Silver and Glycerine Vegetal Soap Granado Traditional
HygieneUnlock trial analytics

Study Endpoints

Primary Endpoints

Transepidermal water loss measurement (TEWL) and corneometry
Up to Week 9

Measures taken at all visits by Tewameter equipment TM 300. The value of the average will be considered for analysis of final results. Corneometry: Measures taken at all visits by Corneometer equipment MPA 580.

Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingNONE
ModelCROSSOVER
PurposeTREATMENT

Treatment Arms

ArmTypeDescription
Group 1EXPERIMENTALDermacyd Silver Frutal followed by Dermacyd Silver Frutal+PH\_DESYLSTY\_FR followed by wash out followed by Glycerine Vegetal Soap Granado Traditional
Group 2EXPERIMENTALGlycerine Vegetal Soap Granado Traditional followed by wash out followed by Dermacyd Silver Floral followed by Dermacyd Silver Floral + PH\_DESYLSTY\_FR

Interventions

NameTypeDescription
Dermacid Silver (Lactic acid)DRUGLiquid soap, daily use
Glycerine Vegetal Soap Granado TraditionalDRUGVegetal soap, daily use
Unlock Study Design Details

Eligibility Criteria

Age Range45 Years to 65 Years
SexFEMALE
Healthy VolunteersNo
Study Sites1

Inclusion criteria: * Active sex life * Menopause for at least 6 months * Perfect mucosa in the evaluated area * Use the same cosmetics category Exclusion criteria: * Use of antiinflammatory / immunosuppression / antihistaminic drugs * Personal history of atopy to cosmetic products * Cutaneous ac...

Countries:Brazil
Unlock Eligibility Criteria

Frequently asked questions about Dermacid Silver

What is Dermacid Silver?

Dermacid Silver is an investigational small molecule developed by Sanofi. It has been studied in a Phase 3 trial in Brazil for hygiene use in women aged 45 years and older. The trial, NCT01126606, compared Dermacid Silver with Glycerine Vegetal Soap Granado Traditional and has been completed.

Who makes Dermacid Silver?

Dermacid Silver is developed by Sanofi, which trades under the ticker SNY. Sanofi sponsored the Phase 3 trial evaluating the product. No other developer or partner is identified for this asset.

What phase is Dermacid Silver in?

Dermacid Silver has completed a Phase 3 clinical trial, NCT01126606. It is an investigational product and is not described as FDA approved. The trial enrolled 70 participants and has a completed status, with no active trials currently listed for this asset.

What clinical trials is Dermacid Silver in?

Dermacid Silver has been studied in one clinical trial, NCT01126606, titled Comparative Safety and Efficacy Evaluation Between Dermacyd Silver and Glycerine Vegetal Soap Granado Traditional. The Phase 3 trial was completed, enrolled 70 participants, was randomized and controlled, and was conducted in Brazil in women aged 45 years and older.

Is Dermacid Silver the same as Dermacid Silver (Lactic acid)?

Yes, Dermacid Silver is also known as Dermacid Silver (Lactic acid). The parenthetical name reflects the lactic acid component associated with the product. Both names refer to the same Sanofi asset studied in the Phase 3 hygiene trial NCT01126606.